- Home
- PCRX vs ARHS Comparison
PCRX vs ARHS Comparison
Compare PCRX & ARHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCRX | ARHS |
|---|---|---|
| Founded | 2006 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 956.8M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PCRX | ARHS |
|---|---|---|
| Price | $25.10 | $7.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $30.25 | $10.78 |
| AVG Volume (30 Days) | 398.4K | ★ 1.2M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.64% |
| EPS Growth | ★ 107.44 | N/A |
| EPS | 0.16 | ★ 0.48 |
| Revenue | $541,533,000.00 | ★ $1,379,222,000.00 |
| Revenue This Year | $6.78 | $7.23 |
| Revenue Next Year | $8.54 | $7.10 |
| P/E Ratio | $158.81 | ★ $15.83 |
| Revenue Growth | ★ 26.04 | 8.51 |
| 52 Week Low | $18.80 | $6.17 |
| 52 Week High | $27.64 | $12.97 |
Technical Indicators
Market Signals| Indicator | PCRX | ARHS |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 49.75 |
| Support Level | $20.56 | $6.17 |
| Resistance Level | $25.23 | $7.61 |
| Average True Range (ATR) | 0.88 | 0.32 |
| MACD | 0.09 | 0.07 |
| Stochastic Oscillator | 65.79 | 44.12 |
Price Performance
Historical ComparisonAbout PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About ARHS Arhaus Inc.
Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in several categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and e-commerce sales channels.